Frailty for cardiovascular risk stratification in CKM syndrome stages 0-3: a UK Biobank prospective cohort study. [PDF]
Wang J, Zhao Y, Ma Z.
europepmc +1 more source
Glucocorticoid resistance-induced inflammation drives cardiovascular-kidney-metabolic (CKM) syndrome pathophysiology. [PDF]
Martinez GJ, Stec DE, Hinds TD.
europepmc +1 more source
Biological and Heart Age Acceleration in CKM Syndrome: Promising Stroke Predictors or Methodological Concerns? [PDF]
Qaseem M.
europepmc +1 more source
Clarifying the role of TyG-VLR in CKM risk characterization: Reply to "Composite metabolic biomarkers for cardiovascular risk assessment in CKM syndrome". [PDF]
Lu AM, Han HJ, Xu Q, Bai SK.
europepmc +1 more source
Age- and sex-specific normative values for reticulocyte indices and their relation to early-stage CKM syndrome. [PDF]
Huang L +10 more
europepmc +1 more source
Mitochondrial Dysfunction at the Intersection of CKM Syndrome: Molecular Mechanisms and Path-to-Target Therapies. [PDF]
Kuo YJ +4 more
europepmc +1 more source
Stage-specific associations of mineralization markers with CKM syndrome: Nationwide survey and genetic evidence for Alkaline phosphatase's unique clinical role. [PDF]
Hua L, Tao Y, Shen L.
europepmc +1 more source
Associations of the CHG index combined with obesity indicators with cardiovascular disease in early CKM syndrome using CHARLS data. [PDF]
Lv L, Guo Y, Li X, Han Q, Wang H.
europepmc +1 more source
TyG and RC combined with CVD risk in CKM syndrome: A national cohort study. [PDF]
Lan H +6 more
europepmc +1 more source
Social Isolation Trajectories Spanning Childhood to Adulthood and Mortality Risk in CKM Syndrome: Evidence From CHARLS. [PDF]
Liang L, Wang X, Chen S, Lin M.
europepmc +1 more source

